InfuSystem Holdings (INFU) Interest Expenses (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Interest Expenses came in at $527000.0 in Q1 2026, down 14.31% YoY from $615000.0 in Q1 2025, and up 11.65% on a QoQ basis from $472000.0 in Q4 2025.
InfuSystem Holdings (INFU) Interest Expenses (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Interest Expenses data on file, last reported at $527000.0 in Q1 2026.
- Quarterly Interest Expenses fell 14.31% year-over-year to $527000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $527000.0 (down 74.64% YoY) and the FY2025 annual result came in at $2.0 million, up 3.05% from the prior year.
- Interest Expenses rose to $527000.0 in Q1 2026, from $472000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $8.5 million in Q2 2025 to a low of $424000.0 in Q4 2022.
- A 5-year average of $989882.4 and a median of $524000.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses tumbled 35.31% — and 2025, when it surged 1593.0%.
- Tracing INFU's Interest Expenses over 5 years: stood at $424000.0 in 2022, then gained by 25.71% to $533000.0 in 2023, then decreased by 13.13% to $463000.0 in 2024, then advanced by 1.94% to $472000.0 in 2025, then grew by 11.65% to $527000.0 in 2026.
- The last three Interest Expenses figures came in at $527000.0 (Q1 2026), $472000.0 (Q4 2025), and $527000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.80 Mn |
| 10 | InfuSystem Holdings | 244.27 Mn | 243.30 Mn | 21.41 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 Mn |
| Jun 30, 2026 | 6.57 Mn |
| Mar 31, 2026 | 527,000.00 |
| Mar 31, 2026 | 527,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Jun 30, 2025 | 8.47 Mn |
| Jun 30, 2025 | 8.47 Mn |
| Mar 31, 2025 | 615,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 463,000.00 |
| Dec 31, 2024 | 463,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Mar 31, 2024 | 530,000.00 |